Research Article
A Pilot Randomized Trial of Preoperative Pelvic Floor Muscle Exercise versus Usual Care to Treat Urinary Incontinence after Robotic-Assisted Radical Prostatectomuy (RARP): A Study Protocol
Maria Angela Cerruto*, Marco Sebben, Marco Pirozzi, Matteo Balzarro, Antonio Porcaro and
Walter Artibani
Department of Surgery, Dentistry Paediatrics and Gynaecology, University of Verona, Italy
*Corresponding author: Maria Angela Cerruto, Department of Surgery, Dentistry Paediatrics and Gynaecology, University of Verona, Italy
Published: 26 May, 2017
Cite this article as: Cerruto MA, Sebben M, Pirozzi M,
Balzarro M, Porcaro A, Artibani W. A
Pilot Randomized Trial of Preoperative
Pelvic Floor Muscle Exercise
versus Usual Care to Treat Urinary
Incontinence after Robotic-Assisted
Radical Prostatectomuy (RARP): A
Study Protocol. Clin Surg. 2017; 2:
1488.
Abstract
Background: Radical prostatectomy represents the most common and effective treatment for
localised prostate cancer. Recently, robot-assisted radical prostatectomy (RARP) has become
increasingly used worldwide. Although a recent systematic review and meta-analysis found
that RARP had higher postoperative continence rates than retropubic or laparoscopic radical
prostatectomy, urinary incontinence (UI) and sexual dysfunction remain the most bothersome
postoperative complications even after RARP. Pelvic floor muscle training (PFMT) may represent a
valid treatment to improve postoperative urinary continence as well as sexual function. The aim of
this study will be to carry out a randomised controlled trial in order to determine a causal relationship
between preoperative PFMT and postoperative functional outcomes in patients undergoing RARP.
Methods/Design: This is a double-arm, single-centre, pilot randomized control trial conducted
at an academic teaching hospital; at least 100 men undergoing RARP for prostate cancer with
no contraindications to PFMT will be recruited and randomized to a pre-and post-operative
PFMT program or usual care. PFMT participants will engage in a PFMT program. The PFMT
prescription will begin with instructions on how to engage the pelvic floor delivered by the research
coordinator trained in PFMT. Usual care participants will not receive any formal training in
PFMT neither preoperatively nor after surgery. Estimates of intervention efficacy will be captured
through measurements at baseline (4–8 weeks preoperatively), within 1 week prior to surgery, and
postoperatively at 4, 12, and 26 weeks. UI will be assessed using the 24-h pad test, a 3-day, bladder
diary. The ICIQ-Urinary Incontinence (ICIQ-UI) will be administered as an additional self-reported
measure of Post-RARP UI. Quality of life (QoL) will be measured using the following widely used
and psychometrically valid and reliable measures, validated in Italian language: The UCLA-PCI and
the Short-Form 36 (SF-36). Additional urological symptoms will be assessed using the valid and
reliable, 7-item International Prostate Symptom Score (IPSS) with its further item on QoL. Erectile
function will be assessed using the 5-item International Index of Erectile Function (IIEF) scale.
Discussion: The primary outcome of this study will be to examine a structured pre-, peri-, and
post-surgical exercise program of PFMT for men undergoing RARP for prostate cancer. This trial
will advance our understanding of strategies aiming at an early recovery of continence and sexual
activity after RARP, and to efficiently and effectively use the pre-and peri-operative period to
optimize post-operative continence and sexual recovery, improving patients’ QoL.
Keywords: Prostate cancer; RARP; PFMT; Randomized controlled trial; Rehabilitation
Introduction
Radical prostatectomy represents the most common and effective treatment for localised
prostate cancer [1]. Most of these patients have favourable cancer control outcomes after surgery
[2]. Unfortunately, a considerable proportion of them may suffer from long‐term surgical
sequelae, including postoperative urinary incontinence (UI) and sexual dysfunction [3], which
can significantly affect patient's quality of life (QoL) and result in both physical and psychosocial
burdens [4].
Recently, robot-assisted radical prostatectomy (RARP) has become increasingly used worldwide.
Although a recent systematic review and meta-analysis found that
RARP had higher postoperative continence rates than retropubic or
laparoscopic radical prostatectomy [5], UI remains one of the most
bothersome postoperative complications even after RARP.
Normally, the pelvic floor muscles (comprised of the internal
sphincter, levatorani, coccygeus, striated urogenital sphincter,
external anal sphincter, ischiocavernosus, and bulbospongiousus)
work in a coordinated fashion to promote urinary control [6,7].
Consequently, pelvic floor muscle training (PFMT), intended to
improve urinary control by increasing the strength, endurance, and
coordination of the pelvic floor muscles and functional activation of
the external sphincter, represents a traditional fist-line intervention,
limited to the post-operative period, to improve continence
recovery after radical prostatectomy. A recent systematic review
and meta-analysis on the role of PFMT on the management of postprostatectomy
incontinence [8], found evidence to suggest that
preoperative PFMT improves early continence rated but not long
term continence rates. The Authors analysed seven studies contained
sufficient quantitative date on post-operative incontinence suitable
for meta-analysis. Only one of them took into account patients
undergone RARP [9]. Moreover, a very few studies addressed the
attention on the possible role of PFMT in improving sexual function
after radical prostatectomy. Recently Geraerts et al. [10] observed
that patients with persistent erectile dysfunction (ED), minimum 12
months after radical prostatectomy, experienced a better recovery of
erectile function (EF) with PFMT compared with patients without
this intervention.
The aim of this study will be to carry out a randomised controlled
trial in order to determine a causal relationship between preoperative
PFMT and postoperative functional outcomes in patients undergoing
RARP. It is an opportunity to examine a comprehensive prerehabilitation
program for these men that may have a profound
influence on surgical preparation by reducing the often chronic
nature of complete recovery from this procedure.
Methods/Design
This study will be a 2-arm, single-centre; pilot randomized
controlled trial to examine the effect of a preoperative PFMT program
versus usual care (UC). The primary objective of this study will be to
report estimates of efficacy on functional outcomes for RARP patients.
This study will be conducted at one Academic teaching hospital, after
receiving the approval from the local research ethics boards.
Participants
We will recruit at least 100 participants (n=50 per site and per
group) consistent with recommended sample sizes for a pilot study
[11]. We anticipate an attrition rate of 20%. Inclusion criteria: Men
aged 40 and 80 years of age with localized PCa (stage cT1- cT2) who
have consented for RARP.
Exclusion criteria: Patients that: 1) are diagnosed with a known
neurological disease, autoimmune connective tissue disorder; 2)
have a prior experience with PFMT by a healthcare provider; 3) have
hypertonic pelvic floor muscles upon baseline evaluation.
Hypertonic pelvic floor is determined by the physical examination
findings of extra pelvic musculoskeletal and connective tissue
examination, as well as the elements of patient history [12]. These
patients who exhibit levator ani hypertonicity (tension myalgia)
will be excluded as they can experience pelvic, urogenital, and rectal
pain; tightness and spasticity; and adverse effects on sexual, urinary,
and bowel function that may be exacerbated with contraction-based
pelvic floor training [13].
Participants will be 1:1 randomized to the UC and PFMT groups.
Blinded allocation of the participants to their treatment groups will
be performed using a generator to create a blocked randomisation
list.
Study arms
Both groups will begin participation in their respective study
arms at the time of randomization following shortly after RARP
scheduling. The duration of the preoperative wait-time (typically 4-8
weeks) will be recorded. All participants signed an informed consent
form explaining the nature of the study previously approved by the
Ethics Committee of our Institution.
PFMT group,
PFMT participants will engage in a PFMX program. The PFMT
prescription will begin with instructions on how to engage the pelvic
floor delivered by the research coordinator (RC) trained in PFMT.
The PFMX prescription will include a gradual increase in repetitions
from 60 per day during weeks 1–2, 120 per day during weeks 3–4, and
180 per day during week 5 to the surgical date [14]. The total number
of repetitions of the PFMT will be divided equally between the
rhythmic contractions (contract and relax over one second) and the
sustained contractions (contract and hold for up to 10 seconds). Total
daily contractions will be divided into multiple sets over the course of
the day, aiming for 10–20 repetitions per set in all positions: sitting,
standing, squatting, and going up and down stairs. Participants
will be instructed to contract with maximal effort during all PFMT
repetitions. Four days after surgery participants will restart the PFMT
with escalating repetition volume every 2 weeks. Twelve days after
surgery indwelling catheter will be removed. Repetition volume
will start at 30–60 repetitions per day during weeks 1–2; 60-120/day
during weeks 3–4; and 120-150/day during weeks 5–6, and 150-180/
day for weeks 7–26 after surgery [15]. Total daily contractions will
be divided into multiple sets over the course of the day, aiming for
10–20 repetitions per set in all positions: sitting, standing, squatting,
ang going up and down stairs. The RC will communicate with the
PFMT participants weekly via phone or email to ensure program
compliance, support appropriate progression, and address any
barriers to exercise that may prevent ongoing participation.
Usual care (UC)
The UC group will not receive any formal training in PFMT
neither preoperatively nor after surgery.
Outcome Measures
Self-report measures will be conducted at: baseline (following
RARP booking, prior to beginning group assignment) approximately
4–8 weeks preoperatively, within 1 week prior to RARP, and at 4, 12,
and 26 weeks postoperatively. All self-reported measures are available
in Italian.
Urinary incontinence
Urinary Incontinence (UI) will be assessed using the 24-h pad
test, a 3-day, bladder diary. The 24-h pad test will be used to measure
UI by assessing the quantity of urine lost in one day. A urinary leakage
pad is measured after a 24-h period and compared to the unused pad
weight and is used to assess the severity of UI [16-18].
Continence is defined as a loss of ≤2 g of urine or the use of one or
less pad per day [18-21]. During the 24-h period that the pad is worn,
the participants will complete a frequency volume chart including
urination frequency, times of UI, and if the pad was ever removed for
a period of time. The 3-day bladder diary is a standard instrument for
self-reporting voiding patterns. Items include fluid intake, frequency
of toilet voids, episode of urine loss, nocturia, number of pads used,
and activity during event for the three-day period. Bladder diaries are
widely used in clinical trials assessing UI after prostatectomy [22-26].
Participants will be instructed to complete these 3 days prior to their
scheduled assessment appointments.
The ICIQ-Urinary Incontinence (ICIQ-UI) will be administered
as an additional self-reported measure of Post-RARP UI. The Impact
of UI on QoL will be further assessed using the Incontinence Quality
of Life Scale (I-QOL). The I-QOL questionnaire developed by Patrick
et al. [27] contains 22 items, each with a five-point Likert-type
response scale, yielding a total score and three subscale scores. Higher
I-QOL scores indicate better levels of quality of life.
Quality of life
QoL will be measured using the following widely used and
psychometrically valid and reliable measures, validated in Italian
language: The UCLA-PCI and the Short-Form 36 (SF-36).
The UCLA-PCI is a disease-specific health-related QoL (HRQOL)
instrument that evaluates sexual, urinary, and bowel function,
and also measures bother, which reflects any distress caused by
dysfunction. The UCLA-PCI has been widely validated in men with
and without prostate cancer from several ethnicities and countries,
and has been translated into and validated in Italian [28].
The SF-36 The is a generic HR-QoL instrument that contains
36 questions assessing eight aspects of HR-QoL, including physical
functioning (PF), role-physical functioning (RP), role-emotional
functioning (RE), vitality (VI), mental health (MH), social functioning
(SF), bodily pain (BP) and general health (GH) [29]. These scales
can also be also grouped into physical (PCS) and mental (MCS)
components scores. The higher the score, the better the results [29].
Additional urological symptoms are assessed using the valid and
reliable, 7-item International Prostate Symptom Score (IPSS) [30,31]
with its further item on QoL. Erectile function is assessed using
the 5-item International Index of Erectile Function (IIEF) scale, a
widely used, psychometrically validated multidimensional self-report
instrument evaluating male sexual function [32,33].
Statistics
Participant characteristics will be summarized using descriptive
statistics (mean, standard deviation, frequency, median, interquartilic
range). The equivalence of groups at baseline in terms of demographic
and clinical variables will be assessed using independent samples
t-tests for continuous variables, the Wilcoxon test for non-normal
distributed variables, and chi-square tests for categorical variables. A
p value < 0.05 will be considered statistically significant.
Discussion
The primary outcome of this study will be to examine a structured pre-, peri-, and post-surgical exercise program of PFMT for men undergoing RARP for prostate cancer. This trial will advance our understanding of strategies aiming at an early recovery of continence and sexual activity after RARP, and to efficiently and effectively use the pre-and peri-operative period to optimize post-operative continence and sexual recovery, improving patients’ QoL.
References
- Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A, et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. Eur Urol. 2011;59(1):88-95.
- Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, et al. SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2011;364(18):1708–17.
- Murphy DG, Kerger M, Crowe H, Peters JS, Costello AJ. Operative details and oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: 400 cases with a minimum of 12 months follow-up. Eur Urol. 2009;55(6):1358–66.
- Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes. J Urol. 2005;173(5):1701–5.
- Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot- assisted radical prostatectomy. Eur Urol. 2012;62(3):405–17.
- Price N, Dawood R, Jackson SR. Pelvic floor exercise for urinary incontinence: a systematic literature review. Maturitas. 2010;67(4):309-15.
- Messelink B, Benson T, Berghmans B, Bo K, Corcos J, Fowler C, et al. Standardization of Terminology of Pelvic Floor Muscle Function and Dysfunction: Report From the Pelvic Floor Clinical Assessment Group of the International Continence Society. Neurourol Urodyn. 2005;24:374–80.
- Chang JI, Lam V, Patel MI. Preoperative Pelvic Floor Muscle Exercise and Postprostatectomy Incontinence: A systematic review and Meta-analysis. Eur Urol. 2016;69:460-67.
- Geraerts I, Van Poppel H, Devoogdt N. Influence of preoperative and postoperative pelvic floor muscle training (PFMT) compared with postoperative PFMT on urinary incontinence after radical prostatectomy: a randomized controlled trial. Eur Urol. 2013;64:766–72.
- Geraerts I, Van Poppel H, Devoogdt N, De Groef A, Fieuws S, Van Kampen M, et al. Pelvic floor muscle training for erectile dysfunction and climacturia 1 year after nerve sparing radical prostatectomy: a randomized controlled trial. Int J Impot Res. 2016;28(1):9-13.
- Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180-91.
- Gray M. Psychometric evaluation of the international prostate symptom score. Urol Nurs. 1998;18(3):175-83.
- Siegel AL. Pelvic Floor Muscle Training in Males: Practical Applications. Urology. 2014;84:1–7.
- Santa Mina D, Matthew AG, Hilton WJ, Darren Au, Rashami Awasthi, Shabbir MH Alibhai, et al. Prehabilitation for med undergoing radical prostatectomy: a multi-centre, pilot randomized controlled trial. BMC Surgery. 2014; 14:89.
- Santa Mina D, Au D, Alibhai SM, Jamnicky L, Faghani N, Hilton WJ, et al. A pilot randomized trial of conventional versus advanced pelvic floor exercises to treat urinary incontinence after radical prostatectomy: a study protocol. BMC Urol. 2015;15:94.
- Bettez M, Tu LM, Carlson K, Jacques Corcos, Jerzy Gajewski, Martine Jolivet, et al. Update: Guidelines for Adult Urinary Incontinence Collaborative Consensus Document for the Canadian Urological Association. Canadian Urological Association. 2012;2012(6):354–63.
- O'Sullivan R, Karantanis E, Stevermuer TL, Allen W, Moore KH. Definition of mild, moderate and severe incontinence on the 24-hour pad test. BJOG. 2004;111(8):859-62.
- Moore KN, Griffiths D, Hughton A. Urinary incontinence after radical prostatectomy: a randomized controlled trial comparing pelvic muscle exercises with or without electrical stimulation. BJU Int. 1999;83(1):57-65.
- Ribeiro LHS, Prota C, Gomes CM, de Bessa J Jr, Boldarine MP, Dall'Oglio MF, et al. Long-Term Effect of Early Postoperative Pelvic Floor Biofeedback on Continence in Men Undergoing Radical Prostatectomy: A Prospective, Randomized, Controlled Trial. J Urol. 2010;184:1034–9.
- vanKampen M, Weerdt WD, Poppel HV, De Ridder D, Feys H, Baert L, et al. Effect of Pelvic-Floor Re-Education on Duration and Degree of Incontinence After Radical Prostatectomy: A Randomised Controlled Trial. Lancet. 2000;355:98–102.
- Lucas MG, Bedretdinova D, Bosch JLHR, Burkhard FC, Cruz F, Nambiar AK, et al. Guidelines on Urinary Incontinence. Arnhem, Netherlands: European Association of Urology. 2013.
- Burgio KL, Goode PS, Urban DA, Umlauf MG, Locher JL, Bueschen A, et al. Preoperative Biofeedback Assisted Behavioral Training to Decrease Post-Prostatectomy Incontinence: A Randomized, Controlled Trial. J Urol. 2006;175:196–201.
- Goode PS, Burgio KL, Johnson TMI, Clay OJ, Roth DL, Markland AD, et al. Behavioral Therapy With or Without Biofeedback and Pelvic Floor Electrical Stimulation for Persistent Postprostatectomy Incontinence: A Randomized Controlled Trial. JAMA. 2011;305:151–9.
- Meaglia JP, Joseph AC, Chang M, Schmidt JD. Post-prostatectomy urinary incontinence: response to behavioral training. J Urol. 1990;144(3):674-6.
- Franke JJ, Gilbert WB, Grier J, Koch MO, Shyr Y, Smith JA Jr. Early post-prostatectomy pelvic floor biofeedback. J Urol. 2000;163(1):191-3.
- Chapman MM. Pelvic Muscle Exercise/Biofeedback for Urinary Incontinence after Prostatectomy: An Education Program. J Cancer Educ. 1997;12:218–23.
- Wagner TH, Patrick DL, Baverndam TG, Martin ML, Buesching DP. Quality of life of persons with urinary incontinence: development of a new measure. Adult Urol. 1996; 47:67–72.
- Gacci M, Livi L, Paiar F, Detti B, Litwin MS, Bartoletti R, et al. Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index. Urology. 2005;66:338-43.
- Stansfeld SA, Roberts R, Foot SP. Assessing the validity of the SF-36 General Health Survey. Qual Life Res. 1997;6(3):217-24.
- Barry MJ, Fowler Jr FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549–57.
- Gray M. Psychometric evaluation of the international prostate symptom score. Urol Nurs. 1998;18(3):175-83.
- Rosen RC, Cappelleri JC, Gendrano III N. The International Index of Erectile Function (IIEF): A State-of-the-Science Review. Int J Impot Res. 2002;14:226–44.
- Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and Evaluation of an Abridged, 5-item Version of the International Index of Erectile Function (IIEF-5) as a Diagnostic Tool for Erectile Dysfunction. Int J Impot Res. 1999;11:319–27.